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Abstract 
Aim: The purpose of this study was to investigate the effect of normal synovial fluid (SF) on 
exposed endogenous tendon-derived cells (TDC) and engrafted mesenchymal stem cells 
(MSCs) within the tendon extracellular matrix.  
Methods: Explants from equine superficial digital flexor (extra-synovial) and deep digital 
flexor tendons (DDFT) from the compressed, intra-synovial and the tensile, extra-synovial 
regions were cultured in allogeneic or autologous SF-media. Human hamstring explants were 
cultured in allogeneic SF. Explant viability was assessed by staining. Proliferation of equine 
monolayer MSCs and TDCs in SF-media and co-culture with DDFT explants was determined 
by alamarblue®. Non-viable Native Tendon matrices (NNTs) were re-populated with MSCs 
or TDCs and cultured in SF-media. Immunohistochemical staining of tendon sections for the 
apoptotic proteins caspase-3, -8 and -9 was performed.  
Results: Contact with autologous or allogeneic SF resulted in rapid death of resident 
tenocytes in equine and human tendon. SF did not affect the viability of equine epitenon 
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cells, or of MSCs and TDCs in monolayer or indirect explant co-culture. MSCs and TDCs, 
engrafted into NNTs, died when cultured in SF.  Caspase-3, -8 and -9 expression was greatest 
in SDFT explants exposed to allogeneic SF.  
Conclusions: The efficacy of cells administered intra-synovially for tendon lesion repair is 
likely to be limited, since once incorporated into the matrix, cells become vulnerable to the 
adverse effects of SF. These observations could account for the poor success rate of intra-
synovial tendon healing following damage to the epitenon and contact with SF, common with 
most soft tissue intra-synovial pathologies. 
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Introduction 
Rotator cuff disease is the third most common orthopaedic complaint in general practice [1, 
2].  It is estimated that rotator cuff tears affect 5-30% of adults (rising to approximately 60% 
of over 60 year olds) and that 40-50% of patients in the UK consult their general practitioners 
for shoulder pain [3, 4]. Despite this high prevalence, both medical and surgical treatment 
modalities are far from universally successful, with re-tear rates as high as 89% in tears 
classified as large or massive [5-7].  Effective repair of injured tissue along with restoration 
of biomechanical properties and cellular organisation is not consistently achieved. Even with 
the use of modern surgical techniques which attempt to bridge ruptured tendon gaps by 
means of grafts coupled with lengthy, costly rehabilitation, 40–50% of patients continue to 
have symptoms and/or considerable functional impairment 1 – 2 years post-diagnosis [8-10]. 
Therefore there remains a strong need to address the reasons for these limitations on 
successful tendon repair.   
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There are no good laboratory models of human tendon disease [11], in part due to the 
anatomical differences between bipeds and quadrupeds.  However, there are striking 
similarities between the horse and human when comparing functionally-similar tendons.  
Thus the equine deep digital flexor tendon (DDFT) in the distal forelimb frequently suffers 
naturally-occurring intra-synovial tears comparable to rotator cuff tears. Both tendons are 
located in a similar biomechanical environment (that of compression), in an intra-synovial 
location, suffer age-related degeneration and demonstrate failed healing with persistent pain. 
Surgical debridement in isolation does not generate acceptable success rates [12] with 60-
62% of horses diagnosed with DDFT tears unable to return to their previous level of work 
and the prognosis worsening to 82% for larger tears [13].  
The intra-synovial location of both these tendons provides different treatment challenges to 
that of extra-synovial tendon injury. Release of extracellular matrix (ECM) proteins [14], 
cytokines [15, 16], and matrix metalloproteinases [17] from the exposed damaged tendon 
surface are important drivers for persistent synovial inflammation. Together with a sustained 
compressive environment, where a tendon sheath or bursa exists to ease movement of the 
tendon over a bony prominence, these factors limit natural tendon healing.  
Mesenchymal stem cells (MSCs) have been defined by their functional capacity to self-renew 
and to generate a range of differentiated progeny [18]. Enhancing natural tendon repair using 
autologous bone marrow-derived MSCs is an attractive concept, which is supported by 
positive results in both clinical and experimental studies in the horse but to date these have 
been limited to extra-synovial tendon injuries [19, 20]. Little is currently known about the 
effect of synovial fluid on implanted cells. Studies have shown suppression of growth rates of 
human chondrocytes [21] and cruciate ligament fibroblasts [22] when using SF with no 
additional nutrient supplementation; when SF was used in combination with cell-specific 
growth medium, chondrocyte culture was deemed feasible [23]. Previous studies have 
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reported that synovial fluid has a deleterious effect on tendon-to-bone healing in an in vivo 
rabbit model [24] but this study measured histological and biomechanical parameters, not 
tissue viability. Clinical observation demonstrates that fluid leakage from a damaged synovial 
cavity results in significant reaction and inflammation of the tissues exposed to the synovial 
fluid, supporting the hypothesis that synovial fluid has adverse effects on tissues not normally 
exposed to it.  
We have previously demonstrated unaffected adherence of MSCs and tendon-dervied cells  
(TDCs) in synovial fluid suspension to the matrix of tendon explants [25] but our 
observations during that study led us to further investigate the gross effect of normal synovial 
fluid on the cells resident in exposed tendon tissue as well as those which might be implanted 
following injury. 
Materials & Methods: 
Collection of tendon: Equine tendons were collected at postmortem under approval from the 
Ethics and Welfare Committee at the Royal Veterinary College (URN 2011–1117). No 
horses were euthanized for the sole purpose of obtaining tissues for this study. 
Macroscopically normal metacarpal tensile region SDFTs as well as DDFTs from both the 
metacarpophalangeal com ressed (C-DDFT) and metacarpal tensile (T-DDFT) regions were 
aseptically harvested from three skeletally mature horses (9 ± 3 years), without orthopaedic 
disease. The tendons were kept in complete medium (D10; DMEM, supplemented with 10% 
v/v fetal bovine serum, 100 U/mL penicillin, and 100 U/mL streptomycin (all from 
Invitrogen, Paisley, UK)) until explant dissection. Explants were prepared using a cutting 
template, which held three cryoblades [26], such that uniform pieces measuring 2 × 0.20 × 
0.20 cm could be cut. Explants were composed of internal (core) tendon tissue and cut along 
the longitudinal axis of the tendon in order to expose an internal surface. In addition, larger 
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explants which included an intact epitenon on one side were prepared by sharp dissection. 
Tendon explants were maintained in D10 in 12-well culture plates (Starlab, Milton Keynes, 
UK) for 24 h prior to experimentation. All culture incubations of tendon and cells, were 
performed under standard culture conditions (37°C in a humidified atmosphere of 5% CO2).  
Human hamstring tendon was supplied by the Oxford Musculoskeletal Biobank (OMB) 
following approval from the Ethics and Welfare Committee at the Royal Veterinary College 
(reference number 2015 0128H) and OMB Access and Development Committee (Oxford 
REC C09/H0606/11). Samples of normal hamstring were obtained from two patients (1 male, 
25 yrs old and 1 female, 27 years old) undergoing cruciate ligament reconstruction surgery 
but otherwise deemed healthy. Further personal or identifying information was not collected. 
Tissue deemed to be surplus was collected at the culmination of surgery. Explants were cut 
with a scalpel blade to measure approximately 2 x 0.5 x 0.2 cm.  
Isolation of cells: Equine bone marrow MSC populations were obtained from surplus cells, 
used therapeutically to treat SDFT lesions in cases referred to our clinic. TDCs were obtained 
from samples of SDFT which were finely diced and digested with pronase (1% w/v in D10) 
for 1 h, then collagenase (0.5% w/v in D10; Worthingtons, UK) for 18 h. Cells were 
recovered following straining of the digest through a 70 µm filter and centrifugation, and 
seeded in culture flasks at 5,000 cells/cm2. Passage 0–Passage 2 (P0–P2) cells were re-
suspended in Cellbanker cell freezing medium (Amsbio, Oxfordshire, UK) and stored in 
liquid nitrogen until use. 
Collection of synovial fluid: Synovial fluid was aseptically aspirated from the carpal joints (to 
obtain adequate volume) of the same horses from which gross tendon samples were obtained 
and immediately centrifuged (at 500 g for 15 min) to pellet any cellular component. The 
supernatant was heated at 60°C for 1 h with regular mixing by inversion to denature 
complement and stored at -20°C prior to use. For experiments, powdered DMEM (Sigma-
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Aldrich, Poole, UK) was reconstituted with equine synovial fluid, to the manufacturer’s 
recommended concentration and supplemented with 10% v/v fetal calf serum, 100 U/mL 
penicillin and 100 U/mL streptomycin (as before). The resultant synovial fluid media (SF-
media) was pH 7.8. For experiments utilising allogeneic SF, samples were pooled to provide 
adequate volume. 
Synovial fluid was also aspirated from the femoropatellar joints of two human patients (one 
male, aged 69 years and one female aged 76 years) undergoing total knee replacement 
surgery, and treated as above. Human SF was not reconstituted with powdered media, since 
prior experimentation with equine SF had shown cell death to be so rapid, nutrition was not 
considered a factor. 
Culture of tendon in synovial fluid: Equine tendon explants were cultured in 2 mL D10 or SF-
media made from autologous SF or allogeneic SF. Paired explants from each horse were 
removed after 30 min, 1, 6 and 24 h and processed for cell viability staining or 
immunohistochemistry. Human tendon explants were cultured in 3mL of D20 (DMEM, 
supplemented as before, but with 20% v/v fetal bovine serum) or SF for 1 h prior to viability 
staining. 
Proliferation of cells in monolayer: To determine the effect of SF-media on cell proliferation, 
20,000 equine MSCs (n=3) and TDCs (n=3) were seeded into wells of a 12 well culture plate 
(Starlab, Milton Keynes, UK) and allowed to adhere overnight. The following day media was 
replaced with 1 mL 10% alamarBlue® reagent (AbD Serotec, Oxfordshire, UK) in D10. 
Cells were incubated for a further 4 h, shielded from light. 100 μL aliquots of media were 
then transferred, in triplicate, to fluoro-microtitre plates (SPL LifeSciences, UK) and 
fluorescence was measured at 570 nm (excitation) and 585 nm (emission) (Infinite M200 
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PRO fluorometer, Tecan, UK).  Media was replaced with 2 mL fresh D10 or SF-media. The 
assay was repeated at 2 and 6 days. 
Co-culture of explants and cells: Equine MSCs and TDCs (10 x 106 cells, n=3 for each cell 
type) were seeded into each well of a 6-well culture dish (BD Biosciences, Durham, NC, 
USA) and allowed to adhere overnight. The next day, transwell inserts (VWR, Leicester, UK) 
were inserted into each well and the upper and lower chambers were filled with SF-media. 
Live C-DDFT explants (one donor per well, n = 3 horses) were then placed into the transwell 
for 1, 4 or 24 h, after which the explant cell viability was assessed. The remaining monolayer 
was washed 3 times with PBS and cell metabolic activity was assessed using the 
alamarBlue® assay as previously described.  
Non-viable Native Tendon Matrices (NNTs): Additional equi e DDFT (n = 3) explants were 
subjected to repeated (minimum 3 cycles) freeze-thaw cycles (-80 °C snap-freeze for > 2 h, 
followed by rapid thaw at 37 °C for 30 min) in order to render all resident tenocytes non-
viable (as assessed by viability staining (data not shown)) [26]. Subsequently, MSCs or TDCs 
(1 x 106 cells, n =3) were co-cultured overnight with NNTs (4 NNTs per well, 2mL D10 per 
well). Following adherence of cells [25] NNTs were cultured for 3 weeks to allow migration 
of cells into the matrix [25]. Re-cellularised NNTs were then incubated with allogeneic SF-
media or fresh D10 for 1 h and cell viability assessed.  
Viability staining: Explants were incubated in phosphate-buffered saline (PBS (Sigma, Poole, 
UK)) containing 2 μM Calcein AM and 4 μM propidium iodide dyes (both from Invitrogen, 
Paisley, UK) for 1 h and then visualized under a fluorescent microscope (Leica, UK) to 
determine the ratio of viable (emission λ 520 nm) to dead (emission λ 610 nm) cells. The 
percentage viability was calculated from an average of 3 fields.  
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Immunohistochemistry: Equine tendon explants (n=3 horses) were fixed in PBS-buffered 
formalin 10% (Sigma, Poole, UK) immediately upon termination of the culture for minimum 
of 2 days. After 48 h, explants were transferred to 100% ethanol (Merck Millipore, UK) for 4 
h and maintained in 70% ethanol. Explants were then processed by dehydration and 
embedded in wax and 8 mm sections were cut and mounted on Super frost slides (Fisher 
Scientific, UK). Sections were probed using equine specific antibodies (Caspase 9 Antibody 
Rabbit pAb (biorbyt, UK); Caspase 3 Antibody Rabbit pAb (LS Bio, UK); Caspase 8 
antibody (N1C1) Rabbit Poly Clonal (Genetex, UK)) all at a final concentration of 1:500 
using the EXPOSE Mouse and Rabbit Specific HRP/DAB Detection IHC kit (Abcam, UK) 
according to the manufacturer’s instructions. Briefly, slides were rehydrated using decreasing 
concentrations of ethanol (100%, 90%, 70% and 50% for 2 min each). After blocking the 
endogenous peroxidase activity using EXPOSE protein block (Abcam, UK), primary 
antibodies were diluted in PBS containing 0.05%Tween 20 (Sigma, Poole, UK) and placed 
on slides (150 µL/ section) overnight at 4ºC.  Secondary antibody and DAB development 
were carried out according to the manufacturer’s instructions. Nuclear counterstain with 
Haematoxylin (15 sec/slide) was conducted prior to mounting the slide using DPX mounting 
media (Sigma, Poole, UK) and 20 mm x 20 mm coverslips.  
Densitometry and analysis of IHC slides: Multiple images of regions of interest (at least 4) 
were taken from each using a camera mounted Leica microscope (Leica, UK; Image ProPlus 
software v.5). Images were analysed using Image J software via Colour Deconvolution plugin 
and integrated density value (IDV) area fraction measurement [27]. Area fraction containing 
the DAB signal was also normalized against the total cell count (using the Haematoxylin 
density) in each image and adjusted for percentage viability.  
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Results  
Approximately 95% of epitenon cells and 50% of tenocytes resident in explants cultured in 
D10 (control explants) remained viable throughout 24 h of the experiment (Figure 1). This is 
similar to previously reported explant viability [28]. Cells within the epitenon exposed to SF 
remained viable (>95% viability after 24 h). In contrast, the viability of SDFT, C-DDFT and 
T-DDFT explants exposed to SF- media decreased rapidly (Figures 1 and 2) such that within 
30 min, explant viability was less than 10%. After 1 h no living cells could be detected in 
explants exposed to SF media. There was no significant difference between allogeneic or 
autologous SF in their effects on cell viability (Figure 2). As a result, all future experiments 
utilised allogeneic SF, due to ease of collection. This experiment was repeated >20 times 
with a variety of normal equine DDFT exposed to autologous SF and resulted each time in 
rapid death of all tendon cells (data not shown).  
Cells within human hamstring remained viable when cultured in D20 (>90% viability at 6 h 
post surgery). Human hamstring explants exposed to allogeneic SF for 1 h contained no 
living tenocytes, however the cells of the vasculature within the tendon ECM remained viable 
in sections of hamstring exposed to SF (Figure 3). 
In contrast to the findings in tendon explants, MSCs and TDCs cultured in SF-media in 
monolayer, on tissue culture plastic, remained viable (Figure 4a, b). In order to determine if 
the exposure of the tendon ECM to SF resulted in the release of a cytotoxic signal, monolayer 
cells were co-cultured with explants. There was no difference in metabolic activity when 
MSC and TDC monolayers co-cultured with C-DDFT explants were exposed to SF or to D10 
(Figure 4 c, d) for up to 24 h. However, the tenocytes resident within C-DDFT explants died 
rapidly on exposure to SF as before.  
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When NNTs re-cellularised with equine MSCs or TDCs were cultured in SF-media for 1 h, 
all cells adhered to the matrix died. In contrast, when re-cellularised NNTs were cultured in 
D10, these cells remained viable (Figure 5).  
Baseline levels of all three caspases were expressed in control tendon explants cultured in 
D10 and in tendon explants cultured in both autologous and allogeneic SF.  Densitometric 
analysis standardised to the percentage of live cells observed within the explants, showed that 
expression was increased in all explants exposed to autologous or allogeneic SF media and 
was greatest in SDFT explants exposed to allogeneic SF media (Figure 6).   
Discussion 
Our experiments have demonstrated that the viability of cells of the synovial lining 
surrounding the tendon (epitenon) are unaffected by synovial fluid, with which it is 
constantly in contact and from which it derives nutrition [29]. However, exposure of the 
tendon core to normal SF, which can happen once the epitenon is damaged, results in the 
rapid death of the native resident cells or those adhered to the exposed matrix. This finding 
may explain why damage to intra-synovial tendons carries such a poor clinical prognosis for 
both the horse and human as the viability of reparative cells is compromised in the injury. 
Death of tenocytes resident within the matrix was extremely rapid. However, the death of 
cells did not result in the release of a diffusible cytotoxic signal (evidenced by successful 
indirect co-culture of a monolayer) indicating that the causal mechanism requires physical 
contact between cells and the ECM. Whilst the non-cellular, extracellular matrix of tendon 
was thought of as a relatively inactive component of tendon, it is now recognised to play 
important roles in energy storage and function [30] and so may also orchestrate apoptotic 
signals. However, such rapid death of resident tenocytes supports a relative lack of 
production of the apoptotic protein cascade as this would require continuing metabolic 
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activity within the condemned cell. As a result, it was not possible to determine whether the 
cell itself initiates apoptosis (intrinsic cell death) or whether this occurs through an external 
stimulus (extrinsic cell death) [31].  
In contrast, both MSCs and TDCs can be successfully cultured in monolayer in media 
composed of synovial fluid, albeit with a reduced rate of proliferation similar to that reported 
with other cell types [21, 22]. The use of SF-media in the current report allows the exclusion 
of nutrient deficiency or complement activation as causal factors, but the reasons for 
suppression of cell proliferation are unknown. The components of synovial fluid require 
further investigation in order to determine the constituents responsible for this effect and the 
mechanism of their interaction with the ECM.  It is intriguing that the cells of the vasculature 
and the epitenon are not affected by the SF.  We assume that the cells within these tissues 
either have a mechanism to protect from the SF or that they also may be susceptible to its 
effect if implanted within the tendon ECM, although we have not investigated this in the 
current work. Our observations that tendon explants co-cultured with cell monolayers die, 
whilst the monolayer remains viable indicates there was no release of cytotoxic paracrine 
factor from the tendon explant nor was there a protective effect of a co-cultured monolayer 
on tendon tissue. 
As we have previously demonstrated, MSCs (derived from bone marrow, or synovial fluid) 
suspended in either normal or inflammatory synovial fluid will adhere to the cut surfaces of a 
tendon explant [25] indicating no diminished viability or adherence capacity under these 
conditions. Throughout tissue culture, surface adherent cells migrate into the matrix to a 
depth of at least 500µm by 21 days and align in the direction of the resident collagen fibres 
and expressing an elongated morphology similar to resident tenocytes [25]. However, once 
these cells become resident within the matrix, they become susceptible to the lethal effects of 
synovial fluid in a similar way to resident tenocytes. This is of significance when considering 
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the use of MSCs for therapy of intra-synovial tendon tears, since although implanted MSCs 
may adhere to the site of tendon injury, engrafted MSCs will subsequently die in situ. Future 
therapies aimed at intra-synovial tendon healing should incorporate a physical repair to the 
epitenon, protecting the tendon ECM from contact with synovial fluid, beneath which MSCs 
can be implanted. 
The human rotator cuff and the equine DDFT share many functional and anatomical 
properties, suffer injuries caused by very similar underlying pathologies and suffer a high rate 
of treatment failure. Human hamstring tendon is also a flexor tendon like the horse DDFT 
and human rotator cuff tendons. Its use during reconstruction of the internal knee ligaments 
in cases of anterior cruciate ligament rupture meant that excess tissue was available for these 
experiments.  It has the advantage of being normal tendon and, although it is normally an 
extrasynovial tendon, it is used intrasynovially during ACL reconstruction.  ACL injuries 
commonly occur in the 30 – 40 year group which is equivalent to the age range of horses 
used.  Therefore, the results of this study are highly relevant for the very common ACL repair 
technique and further supports the horse as an appropriate model for human disease. Damage 
to an intra-synovial tendon, such as the human rotator cuff or the equine deep digital flexor 
tendon causing exposure of core tendon tissue to the cytotoxic effects of synovial fluid, will 
result in death of resident tenocytes. This may explain the poor success rate of current 
treatment modalities and future therapy should investigate methods by which the tendon 
defect can be sealed. Without a physical barrier separating synovial fluid from implanted 
MSCs, cell therapy is unlikely to deliver effective healing. 
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Figure Legends 
Figure 1. Viability of cells in equine tendon and epitenon explants. Live/Dead staining using 
Calcein AM/ propidium iodide of equine explants cultured in control culture media (D10) or 
synovial fluid culture media (SF media); a, b) intact outer epitenon from the compressive 
region of the DDFT; c,d) core SDFT explant; e,f) core DDFT from the tensile region; g,h) 
core DDFT from the compressive region. The compressed region of the DDFT is less cellular 
than the tensile region and cells appear more rounded and do not follow the linear parallel 
pattern observed by tenocytes in either SDFT or T-DDFT. 
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Figure 2. Quantification of equine tendon explant cell viability. Percentage viability of tendon 
explants from a) SDFT; b) tensile region of the deep digital flexor tendon (T-DDFT); c) 
compressed region of the deep digital flexor tendon (C-DDFT) cultured for up to 24 h in 
control culture media (DMEM) or synovial fluid culture media (SF), assayed using Calcein 
AM/ propidium iodide fluorescent cell staining. Data is an average count from a minimum of 
three fields of view. 
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Figure 3. Viability of cells in human hamstring tendon. Live/Dead staining using Calcein 
AM/ propidium iodide; a, d) hamstring cultured in control media (D20); b, e) hamstring 
cultured in allogeneic synovial fluid (SF) for 1 h; c, f) blood vessels located within hamstring 
cultured in allogeneic synovial fluid. 
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Figure 4. Viability of monolayer equine cells in synovial fluid. a,b) Metabolic activity of 
MSCs (n = 2) and TDCs (n = 2) cultured in monolayer for 6 days in either control culture 
media (D10) or synovial fluid culture media (SF), measured using the alamarBlue® assay. 
c,d) Metabolic activity of MSCs (n = 3) and TDCs (n = 3) co-cultured for up to 24 h with 
explants derived from the compressed region of the deep digital flexor tendon. In these 
cultures the alamarBlue® data is referred to as metabolic activity because no significant cell 
proliferation occurs within the 24 h culture period.  However any toxic effect on cells would 
impact mitochondrial activity (which this assay measures).  
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Figure 5. Viability of re-cellularised NNTs. Live/Dead staining using Calcein AM/ propidium 
iodide of a,b) control (uncoated) C-DDFT explant; c,d) MSCs and; e,f) TDCs cultured for 21 
days adhered to C-DDFT explants, then cultured for 1 h in control culture media (DMEM) or 
synovial fluid culture media (SF). 
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Figure 6. Expression of caspases -3, -8 and -9 by SDFT, T-DDFT and C-DDFT explants 
cultured for 1 h in control culture media (D10), autologous or allogeneic synovial fluid 
culture media, expressed as a percentage relative to live cell numbers determined by viability 
staining from paired samples analysed in Figure 2. 
 
 
